INOVIO Pharmaceuticals Reveals Details of $17.5 Million Public Offering for DNA Biotech Expansion INOVIO Pharmaceuticals has announced a public offering worth $17.5 million to support its DNA medicine development. This offering includes shares and warrants, bolstering the company's mission in biotechnology.

INOVIO Pharmaceuticals Reveals Details of $17.5 Million Public Offering for DNA Biotech Expansion #USA #DNA_medicines #Plymouth_Meeting #INOVIO_Pharmaceuticals #HPV_treatment